Dare Bioscience, Inc. — Form 8-K
Filed October 1, 2026 · analyzed by the 8-K Agent
8-K
— Neutral
significance 15/100
What the filing says
Dare Bioscience filed an 8-K on 2026-10-01 under Items 7.01 (Regulation FD Disclosure) and 9.01 (Financial Statements and Exhibits). The filing includes 40 presentation graphics and supporting documents but the actual text content of the 8-K and Exhibit 99.1 is not provided in this EDGAR index—only file metadata and document lists appear. No specific business event, financial data, counterparties, dollar amounts, or dates are disclosed in the accessible text.
Why this rating
Cannot assess material substance; document index only. For $21.3M-cap company, any undisclosed event could be significant, but no facts present to evaluate.
Extracted items
- 7.01 Reg FD disclosure
- 9.01 exhibits
See more from October 1, 2026.
EDGAR·FLOW summarizes public SEC EDGAR filings with automated analysis. Materiality scores and stock-impact predictions are algorithmically generated and are not investment advice. Always verify against the source filing on SEC.gov.